Narang I, Smith J, Bleiker TO. The National Institute for Health and Care Excellence recommends glucose monitoring devices for all patients with Type 1 diabetes: anticipating further increase in cutaneous reactions to these devices. Clin Exp Dermatol 2022 Nov 16:llac076. doi: 10.1093.
PMID: 36653932